SEC Filings

Form SC 13G Apexigen, Inc. Filed by: Decheng Capital China Life Sciences USD Fund II, L.P. Aug 8, 2022 12:19PM

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G

(Rule 13d–102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND 

AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2. 

(Amendment No.__)

 

Apexigen, Inc.

 

(Name of Issuer)

 

Common Stock, par value $ 0.0001 per share

(Title of Class of Securities)

 

03759B102

(CUSIP Number)

 

July 29, 2022

(Date of Event Which... (continue reading...)

Form D/A Everly Vista Canyon Hold Aug 8, 2022 12:18PM .FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color:... (continue reading...)

Form 13F-HR JACOBSON & SCHMITT ADVIS For: Jun 30 Aug 8, 2022 12:18PM .FormData { color: blue; background-color: white; font-size: small; font-family: Times, serif; } .FormDataC { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align: center; } .FormDataR { color: blue; background-color: white; font-size: small; font-family: Times, serif; text-align:... (continue reading...)

Form 424B2 GOLDMAN SACHS GROUP INC Aug 8, 2022 12:18PM

Filed Pursuant to Rule 424(b)(2)

Registration Statement No. 333-253421

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.

 

Subject to Completion. Dated August 8, 2022

GS Finance Corp.

$

S&P 500® Index-Linked Notes due      

guaranteed by

The Goldman... (continue reading...)

Form 424B2 JPMORGAN CHASE & CO Aug 8, 2022 12:18PM

The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these notes in any jurisdiction where the offer or sale is not permitted.

  Subject to completion dated August 8, 2022  

PRICING SUPPLEMENT

Filed Pursuant to Rule 424(b)(2) Registration Statement Nos. 333-236659 and 333-236659-01 Dated... (continue reading...)